Various steroids modulate ␥ -aminobutyric acid (GABA) A receptor-mediated transmission through an allosteric mechanism that is distinct from that of barbiturates and benzodiazepines. Particularly the ring A-reduced metabolites of progesterone: 3 ␣ -hydroxy-5 ␣ -pregnan-20-one (allopregnanolone) and 3 ␣ -hydroxy-5  -pregnan-20-one (pregnanolone), and of deoxycorticosterone: tetrahydro-DOC (THDOC), are potent naturally occurring agonistic modulators of GABA A receptors (reviewed in Majewska 1992;Rupprecht and Holsboer 1999). Earlier studies demonstrated that these neurosteroids exhibit hypnotic properties. Pregnanolone and THDOC have been shown to rapidly promote nonrapid eye movement sleep (non-REMS) in rats (Edgar et al. 1997;Mendelson et al. 1987). Reportedly, pregnanolone also enhances sleep propensity in humans (Schulz et al. 1996). Likewise, allopregnanolone evokes dose-related sleep changes in rats, including a reduced sleep onset latency, an increase in pre-REMS (a substate of non-REMS, which usually precedes REMS), an attenuation of power in the lower frequencies and an elevation of power in the frequency range of sleep spindles in the electroencephalogram (EEG) within non-REMS (Lancel et al. 1997).The sleep effects of THDOC, pregnanolone and allopregnanolone closely match those of other agonistic